Endovascular therapy for acute severe pulmonary embolism

AbstractAcute pulmonary embolism (PE) is a major public health problem and accounts for 100,000 –180,000 deaths per year in the United States. Current prognostic stratification separates acute PE into massive, submassive, and low-risk by the presence or absence of sustained hypotension, RV dysfunction, and myocardial necrosis. Massive, submassive and low-risk PE have mortality rates of 25– 65%, 3%, and<  1%, respectively. In this review we will focus on therapies currently available to manage acute massive and submassive PE.
Source: The International Journal of Cardiovascular Imaging - Category: Radiology Source Type: research